PanTher Therapeutics
Austin, US · Founded 2014 · Delaware corporation · 18 employees on LinkedIn · 4 known investors
PanTher develops targeted cancer therapeutics that deliver drugs directly to tumor sites at high concentrations over extended periods, aiming to improve clinical outcomes while reducing side effects. The platform is designed to be applicable across multiple therapeutic types for oncology treatment.
Founders & leadership
PanTher Therapeutics was founded in 2014 by Laura Indolfi and Elazer Edelman.
LI
Laura IndolfiChief Executive Officer and Co-Founder
EE
Elazer EdelmanCo-founder
Board
DM
DW
Daniel WildmanBoard director
DZ
MP
Maria PalasisBoard director
DT
David TingBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$16M disclosed across 9 rounds · 2015–2025
▶$3MraisedApr 2025 · 26 investors · BiotechnologyRule 506(b)
▶$3MraisedApr 2025 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Laura IndolfiExecutive Officer, Director
- D MackeyDirector
- Daniel WildmanDirector
- Darshana ZaveriDirector
- Maria PalasisDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedDec 2023 · 28 investors · BiotechnologyRule 506(b)
▶$2.7MraisedDec 2023 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John EdwardsDirector
- Daniel WildmanDirector
- Laura IndolfiExecutive Officer, Director
- Manish BhandariDirector
- Maria PalasisDirector
- Darshana ZaveriDirector
- Offering amount
- $5M
- Amount sold
- $2.7M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedDec 2022 · 15 investors · BiotechnologyRule 506(b)
▶$1.3MraisedDec 2022 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Laura IndolfiExecutive Officer, Director
- Maria PalasisDirector
- David TingDirector
- Darshana ZaveriDirector
- Manish BhandariDirector
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJun 2022 · 17 investors · Other Health CareRule 506(b)
▶$1.1MraisedJun 2022 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DARSHANA ZAVERIDirector
- MARIA PALASISDirector
- MANISH BHANDARIDirector
- LAURA INDOLFIExecutive Officer, Director
- DAVID TINGDirector
- Offering amount
- $1.2M
- Amount sold
- $1.1M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedJun 2021 · 59 investors · Other Health CareRule 506(b)
▶$7.3MraisedJun 2021 · 59 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Maria PalasisDirector
- Manish BhandariDirector
- David TingDirector
- Laura IndolfiExecutive Officer, Director
- Darshana ZaveriDirector
- Offering amount
- $7.3M
- Amount sold
- $7.3M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$209.5KraisedMay 2020 · 15 investors · Other Health CareRule 506(b)
▶$209.5KraisedMay 2020 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David TingDirector
- Laura IndolfiExecutive Officer, Director
- Elazer EdelmanDirector
- Offering amount
- $209.5K
- Amount sold
- $209.5K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$268.1KraisedMay 2020 · 6 investors · Other Health CareRule 506(b)
▶$268.1KraisedMay 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elazer EdelmanDirector
- Laura IndolfiExecutive Officer, Director
- David TingDirector
- Offering amount
- $268.1K
- Amount sold
- $268.1K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35KraisedNov 2016 · 1 investors · Other Health CareRule 506(b)
▶$35KraisedNov 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elazer EdelmanDirector
- David TingDirector
- Laura IndolfiExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $35K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with PanTher Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does PanTher Therapeutics do?
- PanTher develops targeted cancer therapeutics that deliver drugs directly to tumor sites at high concentrations over extended periods, aiming to improve clinical outcomes while reducing side effects. The platform is designed to be applicable across multiple therapeutic types for oncology treatment.
- Who founded PanTher Therapeutics?
- PanTher Therapeutics was founded by Laura Indolfi, Elazer Edelman in 2014.
- Who are PanTher Therapeutics's investors?
- PanTher Therapeutics's investors include Catalyst Health Ventures, Angel Physicians Fund, Mission Biocapital, Walnut Venture Associates.
- How much funding has PanTher Therapeutics raised?
- PanTher Therapeutics has disclosed $16M raised across 9 rounds.
- Where is PanTher Therapeutics headquartered?
- PanTher Therapeutics is headquartered in Austin, US.